Search Result |
Top |
Entry | Name | Description | Category | Pathway | Gene |
---|---|---|---|---|---|
H00155 |
Familial hypercholesterolemia Autosomal dominant hypercholesterolaemia |
Familial hypercholesterolaemia (FHCL) is an autosomal dominant disorder caused by deficiency of low density lipoprotein receptor. Other forms of this disorder include hypercholesterolemia caused by mutation ... | Inherited metabolic disorder |
(FHCL1) LDLR [HSA:3949] [KO:K12473] (FHCL1) EPHX2 [HSA:2053] [KO:K08726] (FHCL1) GHR [HSA:2690] [KO:K05080] (FHCL1) PPP1R17 [HSA:10842] [KO:K08067] (FHCL1) APOA2 [HSA:336] [KO:K08758] (FHCL2) APOB [HSA:338] [KO:K14462] (FHCL3) PCSK9 [HSA:255738] [KO:K13050] (FHCL4) LDLRAP1 [HSA:26119] [KO:K12474] |
|
H00254 |
Growth hormone deficiency Pituitary dwarfism |
Growth hormone deficiency, formerly known as Pituitary dwarfism, is a heterogeneous condition characterized by growth retardation with short stature and normal body proportions caused by growth hormone ... | Endocrine and metabolic disease |
(IGHD1A/1B/2) GH1 [HSA:2688] [KO:K05438] (IGHD3) BTK [HSA:695] [KO:K07370] (IGHD4) GHRHR [HSA:2692] [KO:K04584] (CPHD1) POU1F1 [HSA:5449] [KO:K09363] (CPHD2) PROP1 [HSA:5626] [KO:K09327] (CPHD3) LHX3 [HSA:8022] [KO:K09374] (CPHD4) LHX4 [HSA:89884] [KO:K09374] (CPHD5) HESX1 [HSA:8820] [KO:K09354] (CPHD6) OTX2 [HSA:5015] [KO:K18490] (CPHD7/IGHD5) RNPC3 [HSA:55599] [KO:K13157] (CPHD8) ROBO1 [HSA:6091] [KO:K06753] (PD2) GHR [HSA:2690] [KO:K05080] (PHPX) SOX3 [HSA:6658] [KO:K09267] (GHDP) GHSR [HSA:2693] [KO:K04284] |
|
H01700 | Hypopituitarism | Hypopituitarism is a chronic endocrine illness, and is the partial or complete insufficiency of anterior pituitary hormone secretion. Anterior pituitary is composed of five cell types that secrete growth ... | Endocrine and metabolic disease |
GHRH [HSA:2691] [KO:K05260] TRH receptor [HSA:7201] [KO:K04282] |
|
H02035 | Isolated growth hormone deficiency | Isolated growth hormone deficiency (IGHD) is conditions associated with childhood growth failure due to lack of growth hormone (GH) action, and not necessarily associated with other pituitary hormone deficiencies ... | Endocrine and metabolic disease |
(IGHD1A/1B/2) GH1 [HSA:2688] [KO:K05438] (IGHD3) BTK [HSA:695] [KO:K07370] (IGHD4) GHRHR [HSA:2692] [KO:K04584] (IGHD5) RNPC3 [HSA:55599] [KO:K13157] |
|
H02037 |
Laron syndrome Growth hormone insensitivity syndrome Pituitary dwarfism II |
... insensitivity to growth hormone (GH). The disorder is caused by mutations of the gene encoding the GH receptor (GHR), leading to defective functioning of the GH-IGF1 signalling pathway. The main phenotypic feature ... | Endocrine and metabolic disease | GHR [HSA:2690] [KO:K05080] | |
H02106 | Genetic obesity | Obesity predisposes to many diseases. It has a very heterogeneous phenotypic expression and the molecular mechanisms involved in its development are diverse. Although environmental factors are important ... | Endocrine and metabolic disease |
NR0B2 [HSA:8431] [KO:K08563] SDC3 [HSA:9672] [KO:K16337] POMC [HSA:5443] [KO:K05228] GHRL [HSA:51738] [KO:K05254] PPARG [HSA:5468] [KO:K08530] CARTPT [HSA:9607] [KO:K25453] PPARGC1B [HSA:133522] [KO:K17962] ENPP1 [HSA:5167] [KO:K01513] ADRB2 [HSA:154] [KO:K04142] ADRB3 [HSA:155] [KO:K04143] AGRP [HSA:181] [KO:K05231] UCP1 (polymorphism) [HSA:7350] [KO:K08769] UCP3 [HSA:7352] [KO:K15103] (BMIQ4) UCP2 [HSA:7351] [KO:K15103] (BMIQ9) MC3R [HSA:4159] [KO:K04201] (BMIQ10) FFAR4 [HSA:338557] [KO:K08425] (BMIQ11) SLC6A14 [HSA:11254] [KO:K05047] (BMIQ12) PCSK1 [HSA:5122] [KO:K01359] (BMIQ14) FTO [HSA:79068] [KO:K19469] (BMIQ17) AQP7 [HSA:364] [KO:K08771] (BMIQ18) MRAP2 [HSA:112609] [KO:K25968] (BMIQ19) ADCY3 [HSA:109] [KO:K08043] (BMIQ20) MC4R [HSA:4160] [KO:K04202] |
[ KEGG | DISEASE | DRUG | MEDICUS ] |